Kezar Life Sciences, Inc.

This was a first-in-human study to test the safety and find the right dose of a new drug called KZR-261 for people with advanced solid tumors that had stopped responding to standard treatments. The trial enrolled 61 participants with cancers like melanoma, mesothelioma, colorecta…

This study tested whether a new drug, zetomipzomib, could help control active lupus nephritis, a serious kidney disease caused by lupus. About 84 patients received either the drug or a placebo as a weekly injection for a year, in addition to their standard care. The main goal was…